{"nct_id":"NCT02319005","title":"ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)","status":"COMPLETED","status_verified_date":"2018-06","start_date":"2014-12","start_date_type":null,"primary_completion_date":"2017-03-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-03-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ALNY"]}